Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to rev...

Descripción completa

Detalles Bibliográficos
Autor principal: Cairns, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2014
Materias:
Conference Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263526/
https://www.ncbi.nlm.nih.gov/pubmed/25525466
http://dx.doi.org/10.3332/ecancer.2014.488
_version_ 1782348589030178816
author Cairns, Linda
author_facet Cairns, Linda
author_sort Cairns, Linda
collection PubMed
description Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate.
format Online
Article
Text
id pubmed-4263526
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-42635262014-12-18 Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials Cairns, Linda Ecancermedicalscience Conference Report Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate. Cancer Intelligence 2014-12-08 /pmc/articles/PMC4263526/ /pubmed/25525466 http://dx.doi.org/10.3332/ecancer.2014.488 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Conference Report
Cairns, Linda
Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials
title Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials
title_full Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials
title_fullStr Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials
title_full_unstemmed Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials
title_short Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials
title_sort eurocan platform meeting: european recommendations for biomarker-based chemoprevention trials
topic Conference Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263526/
https://www.ncbi.nlm.nih.gov/pubmed/25525466
http://dx.doi.org/10.3332/ecancer.2014.488
work_keys_str_mv AT cairnslinda eurocanplatformmeetingeuropeanrecommendationsforbiomarkerbasedchemopreventiontrials

Ejemplares similares